Andrea S. Blevins Primeau, PhD, MBA

Researchers sought to determine whether linvoseltamab would improve responses in patients with relapsed/refractory multiple myeloma.

Adding isatuximab to carfilzomib and dexamethasone does not improve overall survival in patients with relapsed/refractory multiple myeloma, data from the IKEMA trial suggest.

Local therapy improves overall survival in patients with clinically lymph node-positive prostate cancer, a meta-analysis suggests.

Researchers say they have identified adverse events that are more likely to occur in cancer patients receiving antibody-drug conjugates.

In a recent survey, 70% of cancer patients said they use complementary or alternative medicine as part of their cancer care.

Researchers sought to determine whether treatment for CLL in veterans with targeted therapies would lead to longer survival than chemotherapy or monoclonal antibodies.

Adding HIPEC to interval cytoreductive surgery improves long-term outcomes in stage III epithelial ovarian cancer, a phase 3 trial suggests.

Breast cancer patients without axillary lymph node involvement who have tumors no larger than 2 cm can safely forgo axillary surgery, a phase 3 trial suggests.

Researchers say they have detected breast cancer in ctDNA from breast milk, and breast milk may allow for earlier cancer detection than plasma.

Researchers sought to determine whether screening patients with MM after ASCT with FDG-PET would be able to identify patients with residual disease.